# CBIT+TMS R33 Phase

> **NCT06678737** · PHASE2 · RECRUITING · sponsor: **University of Minnesota** · enrollment: 60 (estimated)

## Conditions studied

- Tics
- Tourette Syndrome

## Interventions

- **OTHER:** CBIT +cTBS
- **OTHER:** CBIT +sham cTBS

## Key facts

- **NCT ID:** NCT06678737
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-27
- **Primary completion:** 2030-07-15
- **Final completion:** 2030-07-15
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06678737

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06678737, "CBIT+TMS R33 Phase". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT06678737. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*